Gastric Inflammatory Myofibroblastic Tumor: a Case Report
Overview
Authors
Affiliations
Background: Inflammatory myofibroblastic tumor (IMT) of the stomach is an uncommon mesenchymal neoplasm. We present a case of gastric submucosal tumor (SMT) where the final diagnosis was IMT.
Case Presentation: A 69-year-old man presented with a 24-mm SMT on the posterior wall of the middle third of the stomach that was detected by screening upper gastrointestinal endoscopy. Abdominal contrast-enhanced computed tomography showed that the tumor was well-enhanced. Although endoscopic ultrasonography-guided biopsy was performed, the histological diagnosis was not confirmed preoperatively. Since the tumor was clinically suspected to be a gastrointestinal stromal tumor, we performed gastric wedge resection by laparoscopic-endoscopic cooperative surgery. Pathologically, proliferative spindle cells with a positive reaction for smooth muscle actin, negativity for c-kit, desmin, s-100, CD34, STAT-6, β-catenin and anaplastic lymphoma kinase 1 were identified. Hence, the tumor was finally diagnosed as an IMT originating from the stomach.
Conclusions: When an SMT of the stomach is identified, the possibility of gastric IMT should be considered.
A Diagnosis of Gastric Inflammatory Myofibroblast Tumor: A Challenge Like No Other!.
Chukkalore D, Loeffler J, Rabah H, Amarnath S, Al Moussawi H, Deeb L ACG Case Rep J. 2024; 11(7):e01416.
PMID: 38988714 PMC: 11236408. DOI: 10.14309/crj.0000000000001416.